BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 23459935)

  • 1. Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy.
    Wasala NB; Bostick B; Yue Y; Duan D
    Hum Mol Genet; 2013 Jul; 22(13):2634-41. PubMed ID: 23459935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular phenotype of the
    Szabó PL; Ebner J; Koenig X; Hamza O; Watzinger S; Trojanek S; Abraham D; Todt H; Kubista H; Schicker K; Remy S; Anegon I; Kiss A; Podesser BK; Hilber K
    Dis Model Mech; 2021 Feb; 14(2):. PubMed ID: 33619211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced dimethylarginine degradation improves coronary flow reserve and exercise tolerance in Duchenne muscular dystrophy carrier mice.
    Garbincius JF; Merz LE; Cuttitta AJ; Bayne KV; Schrade S; Armstead EA; Converso-Baran KL; Whitesall SE; D'Alecy LG; Michele DE
    Am J Physiol Heart Circ Physiol; 2020 Sep; 319(3):H582-H603. PubMed ID: 32762558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of exercised induced cardiomyopathy following Pip-PMO treatment in dystrophic mdx mice.
    Betts CA; Saleh AF; Carr CA; Hammond SM; Coenen-Stass AM; Godfrey C; McClorey G; Varela MA; Roberts TC; Clarke K; Gait MJ; Wood MJ
    Sci Rep; 2015 Mar; 5():8986. PubMed ID: 25758104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute AT
    Meyers TA; Heitzman JA; Krebsbach AM; Aufdembrink LM; Hughes R; Bartolomucci A; Townsend D
    J Mol Cell Cardiol; 2019 Mar; 128():51-61. PubMed ID: 30664850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uniform low-level dystrophin expression in the heart partially preserved cardiac function in an aged mouse model of Duchenne cardiomyopathy.
    Wasala NB; Yue Y; Vance J; Duan D
    J Mol Cell Cardiol; 2017 Jan; 102():45-52. PubMed ID: 27908661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
    Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
    Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilization of the cardiac sarcolemma by sarcospan rescues DMD-associated cardiomyopathy.
    Parvatiyar MS; Brownstein AJ; Kanashiro-Takeuchi RM; Collado JR; Dieseldorff Jones KM; Gopal J; Hammond KG; Marshall JL; Ferrel A; Beedle AM; Chamberlain JS; Renato Pinto J; Crosbie RH
    JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31039133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcolipin haploinsufficiency prevents dystrophic cardiomyopathy in
    Mareedu S; Pachon R; Thilagavathi J; Fefelova N; Balakrishnan R; Niranjan N; Xie LH; Babu GJ
    Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H200-H210. PubMed ID: 33216625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A microtubule-connexin-43 regulatory link suppresses arrhythmias and cardiac fibrosis in Duchenne muscular dystrophy mice.
    Himelman E; Nouet J; Lillo MA; Chong A; Zhou D; Wehrens XHT; Rodney GG; Xie LH; Shirokova N; Contreras JE; Fraidenraich D
    Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H983-H995. PubMed ID: 36206047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane sealant Poloxamer P188 protects against isoproterenol induced cardiomyopathy in dystrophin deficient mice.
    Spurney CF; Guerron AD; Yu Q; Sali A; van der Meulen JH; Hoffman EP; Nagaraju K
    BMC Cardiovasc Disord; 2011 May; 11():20. PubMed ID: 21575230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergent dilated cardiomyopathy caused by targeted repair of dystrophic skeletal muscle.
    Townsend D; Yasuda S; Li S; Chamberlain JS; Metzger JM
    Mol Ther; 2008 May; 16(5):832-5. PubMed ID: 18414480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiomyopathy in the dystrophin/utrophin-deficient mouse model of severe muscular dystrophy is characterized by dysregulation of matrix metalloproteinases.
    Delfín DA; Zang KE; Schill KE; Patel NT; Janssen PM; Raman SV; Rafael-Fortney JA
    Neuromuscul Disord; 2012 Nov; 22(11):1006-14. PubMed ID: 22749475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sunitinib inhibits STAT3 phosphorylation in cardiac muscle and prevents cardiomyopathy in the mdx mouse model of Duchenne muscular dystrophy.
    Oliveira-Santos A; Dagda M; Burkin DJ
    Hum Mol Genet; 2022 Jul; 31(14):2358-2369. PubMed ID: 35157045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased connective tissue growth factor associated with cardiac fibrosis in the mdx mouse model of dystrophic cardiomyopathy.
    Au CG; Butler TL; Sherwood MC; Egan JR; North KN; Winlaw DS
    Int J Exp Pathol; 2011 Feb; 92(1):57-65. PubMed ID: 21121985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy.
    Bostick B; Shin JH; Yue Y; Wasala NB; Lai Y; Duan D
    J Mol Cell Cardiol; 2012 Aug; 53(2):217-22. PubMed ID: 22587991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac consequences to skeletal muscle-centric therapeutics for Duchenne muscular dystrophy.
    Townsend D; Yasuda S; Chamberlain J; Metzger JM
    Trends Cardiovasc Med; 2009 Feb; 19(2):50-55. PubMed ID: 19577712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dystrophin-deficient cardiomyopathy in mouse: expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart.
    Spurney CF; Knoblach S; Pistilli EE; Nagaraju K; Martin GR; Hoffman EP
    Neuromuscul Disord; 2008 May; 18(5):371-81. PubMed ID: 18440230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.
    Chun JL; O'Brien R; Song MH; Wondrasch BF; Berry SE
    Stem Cells Transl Med; 2013 Jan; 2(1):68-80. PubMed ID: 23283493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.